Dyspnea News and Research

RSS
Dyspnea or dyspnoea or shortness of breath is a debilitating symptom that is the experience of unpleasant or uncomfortable respiratory sensations.

Further Reading

Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms

Study suggests lingering coronavirus in tissues may contribute to long COVID symptoms

Beta-blockers show no benefit for heart attack patients with normal heart function

Beta-blockers show no benefit for heart attack patients with normal heart function

Remote monitoring for COVID-19 patients shows no benefit from pulse oximetry

Remote monitoring for COVID-19 patients shows no benefit from pulse oximetry

Study reveals how long COVID can affect brain function through vascular disruption

Study reveals how long COVID can affect brain function through vascular disruption

Trial investigates efficacy of online supervised group mental and physical rehabilitation program for long COVID patients

Trial investigates efficacy of online supervised group mental and physical rehabilitation program for long COVID patients

Long COVID in children: A closer look reveals lasting impacts

Long COVID in children: A closer look reveals lasting impacts

Higher dietary niacin intake linked to lower COPD risk, study finds

Higher dietary niacin intake linked to lower COPD risk, study finds

Study tracks health and quality of life in chronically critically ill COVID-19 patients months after hospital discharge

Study tracks health and quality of life in chronically critically ill COVID-19 patients months after hospital discharge

Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Study reveals high insomnia rates in non-hospitalized COVID-19 survivors

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Morphine shows potential as effective cough therapy for pulmonary fibrosis, study finds

Study finds vaccination against COVID-19 consistently reduced the risk of long COVID symptoms

Study finds vaccination against COVID-19 consistently reduced the risk of long COVID symptoms

Vaccination provides moderate protection against long COVID in children

Vaccination provides moderate protection against long COVID in children

Immune dysregulation in long COVID patients uncovered in new study

Immune dysregulation in long COVID patients uncovered in new study

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Comprehensive insights on pathophysiology and clinical management of atrial fibrillation

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

Are pan-coronavirus vaccines an achievable goal in providing broad protection against human coronaviruses?

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Intranasal COVID-19 vaccine shows promise in reducing severe symptoms

Deep learning and machine learning prognostic models for chronic obstructive pulmonary disease

Deep learning and machine learning prognostic models for chronic obstructive pulmonary disease

Omicron infection linked to brain structure changes in men, study finds

Omicron infection linked to brain structure changes in men, study finds

Researchers develop a new early alert model for pandemic predictions in Germany

Researchers develop a new early alert model for pandemic predictions in Germany

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.